← back to search

Yasutaka Watanabe

Saitama Cancer Center ·
Area of research
Pulmonary and Respiratory Medicine · Oncology
Research interest
Research interests include Lung Cancer Treatments and Mutations, Lung Cancer Research Studies, Cancer Immunotherapy and Biomarkers, and Lung Cancer Diagnosis and Treatment.
h-index
14
citations
1,083
works
71
NIH funding
primary concept
Medicine
email

Recent publications

Clinical outcomes with perioperative nivolumab by nodal status in patients with stage III resectable NSCLC: phase 3 CheckMate 77T exploratory analysis
Nature Cancer 2026cited by 1position: middledoi
Perioperative Nivolumab in Resectable Lung Cancer
New England Journal of Medicine 2024cited by 413position: middledoi
Clinical outcomes with perioperative nivolumab (NIVO) by nodal status among patients (pts) with stage III resectable NSCLC: Results from the phase 3 CheckMate 77T study.
Journal of Clinical Oncology 2024cited by 21position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Padma Sathyanarayana · Bristol-Myers Squibb (United States)2 papers (2024–2026) · 2 papers (2024–2026)Jonathan Spicer · McGill University Health Centre2 papers (2024–2026)Tina Cascone · The University of Texas MD Anderson Cancer Center2 papers (2024–2026)Fábio Franke · Grupo Hospitalar Conceição2 papers (2024–2026)Mariano Provencio · First Affiliated Hospital of Guangzhou Medical University2 papers (2024–2026)Mark M. Awad · PCAS (France)2 papers (2024–2026)Cinthya Coronado Erdmann · Bristol-Myers Squibb (United States)2 papers (2024–2026)Aurelia Alexandru · Ovidius University2 papers (2024–2026)Fedor V. Moiseyenko · State Budget Institution of Health St. Petersburg Clinical Research Center Specialized Types of Medical Care1 papers (2026–2026) · 1 papers (2026–2026) · 1 papers (2026–2026) · 1 papers (2026–2026) · 1 papers (2026–2026) · 1 papers (2026–2026) · 1 papers (2026–2026) · 1 papers (2026–2026) · 1 papers (2026–2026) · 1 papers (2024–2024)Annelies Janssens · Janssen (Belgium)1 papers (2024–2024)